Indication
Vulvovaginal Candidiasis
6 clinical trials
11 products
Product
IbrexafungerpClinical trial
Oral Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis (VVC) in Subjects Who Have Failed Fluconazole TherapyStatus: Completed, Estimated PCD: 2023-05-16
Clinical trial
Randomized Controlled Trial to Assess the Effectiveness of a Zinc-containing Vaginal Gel and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis.Status: Recruiting, Estimated PCD: 2024-12-31
Product
FluconazoleProduct
Butoconazole NitrateProduct
PlaceboClinical trial
A Randomized Study Evaluating the Therapeutic Equivalence and Safety of Butoconazole Nitrate Vaginal Cream, 2% and Gynazole 1 (Butoconazole Nitrate) Vaginal Cream, 2%, Against a Vehicle Control in the Treatment of Vulvovaginal CandidiasisStatus: Completed, Estimated PCD: 2009-09-01
Product
JUVIAProduct
Gynazole 1Clinical trial
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product (BGY-1601-VT) as a First-line Monotherapy in Women With Acute Vaginal Infection: a Randomized, Double-blind, Placebo-controlled StudyStatus: Not yet recruiting, Estimated PCD: 2025-12-28
Product
BGY-1601-VTClinical trial
Efficacy and Safety of Vaginal Suppositories Containing Combination of Natamycin and Lactulose in Treatment of Vulvovaginal Candidiasis: International, Randomized, Controlled, Superiority Clinical TrialStatus: Completed, Estimated PCD: 2023-07-26
Product
Natamycin + LactuloseProduct
LactuloseProduct
PimafucinClinical trial
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal MicrobiomeStatus: Recruiting, Estimated PCD: 2023-06-30
Product
Phexxi